Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

New data show improved outcomes in resectable pancreatic cancer with PAXG chemotherapy over standard mFOLFIRINOX, but should ...

The team has been awarded a $2.5 million grant to develop a system for inserting tiny light-emitting fibers directly into ...

Team awarded $2.5 million grant to develop system for inserting tiny light-emitting fibers directly into tumors.

Team awarded $2.5 million grant to develop system for inserting tiny light-emitting fibers directly into tumors.

OSE Immunotherapeutics has shared survival data behind a therapeutic vaccine’s phase 2 pancreatic cancer win as the French ...

Researchers have discovered that plant-derived phytochemicals and their gut microbiome metabolites control the effectiveness ...

Victor Conte, the controversial and self-described reformed supervisor of several elite boxers’ conditioning programs, has ...

Nplate improved platelet response and reduced therapy modification for patients with chemotherapy-induced thrombocytopaenia.

Amgen Inc. (NASDAQ: AMGN )’s thrombocytopenia drug Nplate (romiplostim) showed significant benefits in a Phase III trial for ...

Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...